EDITORIALS

New Treatments for Advanced Hodgkin’s Disease: An Uphill Fight Beginning Close to the Top

George P. Canellos

JCO Feb 1 2002: 607–609. [Full Text] [PDF]

Tumor Hypoxia: Chicken, Egg, or a Piece of the Farm?

C. Norman Coleman, James B. Mitchell, and Kevin Camphausen

JCO Feb 1 2002: 610–615. [Full Text] [PDF]

Why Do We Still Use Hormone Replacement Therapy? Why Don’t We Use It More?

Victor G. Vogel

JCO Feb 1 2002: 616–619. [Full Text] [PDF]

Can We Cure Limited Metastatic Breast Cancer?

Gabriel N. Hortobagyi

JCO Feb 1 2002: 620–623. [Full Text] [PDF]

Attending to Psychologic Symptoms and Palliative Care

Manish Agrawal and Ezekial J. Emanuel

JCO Feb 1 2002: 624–626. [Full Text] [PDF]

Prognostic Factors for Sarcomas: Hard and Soft

Paul Meyers

JCO Feb 1 2002: 627–629. [Full Text] [PDF]

ORIGINAL REPORTS
Hematologic Malignancies
	Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial
	Sandra J. Horning, Richard T. Hoppe, Sheila Breslin, Nancy L. Bartlett, B. William Brown, and Saul A. Rosenberg
	JCO Feb 1 2002: 630–637. [Abstract] [Full Text] [PDF]
	Risk of Second Cancer in Patients With Hairy Cell Leukemia: Long-Term Follow-Up
	Massimo Federico, Pier Luigi Zinzani, Antonio Frassoldati, Marco Vinceti, Alessia Modè, Luciana Annino, Teodoro Chisesi, Guido Pagnucco, Rosangela Invernizzi, Mauro Spriano, Luigi Resegotti, Maurizio Bendandi, and Eugenio E. Damasio
	JCO Feb 1 2002: 638–646. [Abstract] [Full Text] [PDF]
	Primary Cutaneous Follicular Lymphoma: An Assessment of Clinical, Histopathologic, Immunophenotypic, and Molecular Features
	I. Mirza, N. Macpherson, S. Paproski, R. D. Gascoyne, B. Yang, W. G. Finn, and E. D. Hsi
	JCO Feb 1 2002: 647–655. [Abstract] [Full Text] [PDF]
	Phase II Study of Troxacitabine, a Novel Dioxolane Nucleoside Analog, in Patients With Refractory Leukemia
	Francis J. Giles, Guillermo Garcia-Manero, Jorge E. Cortes, Sharyn D. Baker, Carol B. Miller, Susan M. O'Brien, Deborah A. Thomas, Michael Andreeff, Carol Bivins, Jacques Jolivet, and Hagop M. Kantarjian
	JCO Feb 1 2002: 656–664. [Abstract] [Full Text] [PDF]
	Prolonged Infusion of Gemcitabine: Clinical and Pharmacodynamic Studies During a Phase I Trial in Relapsed Acute Myelogenous Leukemia
	Varsha Gandhi, William Plunkett, Min Du, Mary Ayres, and Elihu H. Estey
	JCO Feb 1 2002: 665–673. [Abstract] [Full Text] [PDF]
	Phase I Evaluation of Prolonged-Infusion Gemcitabine With Mitoxantrone for Relapsed or Refractory Acute Leukemia
	David A. Rizzieri, Adam J. Bass, Gary L. Rosner, Jon P. Gockerman, Carlos M. DeCastro, William P. Petros, David J. Adams, Mary J. Laughlin, Patti Davis, Traci Foster, Robert Jacobson, Herbert Hurwitz, and Joseph O. Moore
	JCO Feb 1 2002: 674–679. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer
	A. Fyles, M. Milosevic, D. Hedley, M. Pintilie, W. Levin, L. Manchul, and R. P. Hill
	JCO Feb 1 2002: 680–687. [Abstract] [Full Text] [PDF]
	Lymphatic Mapping and Sentinel Node Identification in Patients With Cervix Cancer Undergoing Radical Hysterectomy and Pelvic Lymphadenectomy
	Charles Levenback, Robert L. Coleman, Thomas W. Burke, W. Michael Lin, William Erdman, Michael Deavers, and Ebrahim S. Delpassand
	JCO Feb 1 2002: 688–693. [Abstract] [Full Text] [PDF]
	Intraperitoneal Chemotherapy for Ovarian Carcinoma: Results of Long-Term Follow-Up
	Richard R. Barakat, Paul Sabbatini, Dharmendra Bhaskaran, Margarita Revzin, Alex Smith, Ennapadam Venkatraman, Carol Aghajanian, Martee Hensley, Steven Soignet, Carol Brown, Robert Soslow, Maurie Markman, William J. Hoskins, and David Spriggs
	JCO Feb 1 2002: 694–698. [Abstract] [Full Text] [PDF]

Breast Cancer
	Does Menopausal Hormone Replacement Therapy Interact With Known Factors to Increase Risk of Breast Cancer?
	Giske Ursin, Chiu-Chen Tseng, Annlia Paganini-Hill, Shelley Enger, Peggy C. Wan, Silvia Formenti, Malcolm C. Pike, and Ronald K. Ross
	JCO Feb 1 2002: 699–706. [Abstract] [Full Text] [PDF]
	Prognostic Model for Relapse After High-Dose Chemotherapy With Autologous Stem-Cell Transplantation for Stage IV Oligometastatic Breast Cancer
	Yago Nieto, Samia Nawaz, Roy B. Jones, Elizabeth J. Shpall, Pablo J. Cagnoni, Peter A. McSweeney, Anna Barón, Carrington Razook, Steve Matthes, and Scott I. Bearman
	JCO Feb 1 2002: 707–718. [Abstract] [Full Text] [PDF]
	Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
	Charles L. Vogel, Melody A. Cobleigh, Debu Tripathy, John C. Gutheil, Lyndsay N. Harris, Louis Fehrenbacher, Dennis J. Slamon, Maureen Murphy, William F. Novotny, Michael Burchmore, Steven Shak, Stanford J. Stewart, and Michael Press
	JCO Feb 1 2002: 719–726. [Abstract] [Full Text] [PDF]
	Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer
	F.A. Holmes, J.A. O’Shaughnessy, S. Vukelja, S.E. Jones, J. Shogan, M. Savin, J. Glaspy, M. Moore, L. Meza, I. Wiznitzer, T.A. Neumann, L.R. Hill, and B.C. Liang
	JCO Feb 1 2002: 727–731. [Abstract] [Full Text] [PDF]
	Association of Angiogenesis and Disease Outcome in Node-Positive Breast Cancer Patients Treated With Adjuvant Cyclophosphamide, Doxorubicin, and Fluorouracil: A Cancer and Leukemia Group B Correlative Science Study From Protocols 8541/8869
	Anthony J. Guidi, Donald A. Berry, Gloria Broadwater, Birgit Helmchen, Ira J. Bleiweiss, Daniel R. Budman, I. Craig Henderson, Larry Norton, and Daniel F. Hayes
	JCO Feb 1 2002: 732–742. [Abstract] [Full Text] [PDF]
	High-Dose Versus Standard Chemotherapy in Metastatic Breast Cancer: Comparison of Cancer and Leukemia Group B Trials With Data From the Autologous Blood and Marrow Transplant Registry
	Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Mary Costanza, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy, Jr, Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz
	JCO Feb 1 2002: 743–750. [Abstract] [Full Text] [PDF]
	Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study
	Jürgen Geisler, Ben Haynes, Gun Anker, Mitch Dowsett, and Per Eystein Lønning
	JCO Feb 1 2002: 751–757. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Practices and Attitudes of Japanese Oncologists and Palliative Care Physicians Concerning Terminal Sedation: A Nationwide Survey
	Tatsuya Morita, Tatsuo Akechi, Yuriko Sugawara, Satoshi Chihara, and Yosuke Uchitomi
	JCO Feb 1 2002: 758–764. [Abstract] [Full Text] [PDF]
	Can Communication Skills Training Alter Physicians’ Beliefs and Behavior in Clinics?
	Valerie Jenkins and Lesley Fallowfield
	JCO Feb 1 2002: 765–769. [Abstract] [Full Text] [PDF]
	Comprehensive Assessment of the Elderly Cancer Patient: The Feasibility of Self-Report Methodology
	Sally S. Ingram, Pearl H. Seo, Robert E. Martell, Elizabeth C. Clipp, Martha E. Doyle, Gustavo S. Montana, and Harvey J. Cohen
	JCO Feb 1 2002: 770–775. [Abstract] [Full Text] [PDF]

Sarcomas
	Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
	Stefan S. Bielack, Beate Kempf-Bielack, Günter Delling, G. Ulrich Exner, Silke Flege, Knut Helmke, Rainer Kotz, Mechthild Salzer-Kuntschik, Matthias Werner, Winfried Winkelmann, Andreas Zoubek, Heribert Jürgens, and Kurt Winkler
	JCO Feb 1 2002: 776–790. [Abstract] [Full Text] [PDF]
	Postoperative Nomogram for 12-Year Sarcoma-Specific Death
	Michael W. Kattan, Denis H.Y. Leung, and Murray F. Brennan
	JCO Feb 1 2002: 791–796. [Abstract] [Full Text] [PDF]

Lung Cancer
	Phase II Study of Twice-Daily High-Dose Thoracic Radiotherapy Alternating With Cisplatin and Vindesine for Unresectable Stage III Non–Small-Cell Lung Cancer: Japan Clinical Oncology Group Study 9306
	Ikuo Sekine, Yutaka Nishiwaki, Takashi Ogino, Akira Yokoyama, Mari Saito, Kiyoshi Mori, Iwao Tsukiyama, Satoshi Tsuchiya, Kazushige Hayakawa, Kimio Yoshimura, Naoki Ishizuka, and Nagahiro Saijo
	JCO Feb 1 2002: 797–803. [Abstract] [Full Text] [PDF]
	Phase I Trial of Weekly Gemcitabine and Concurrent Radiotherapy in Patients With Inoperable Non–Small-Cell Lung Cancer
	Lucio Trodella, Pierluigi Granone, Salvatore Valente, Adriana Turriziani, Giuseppe Macis, Giuseppe M. Corbo, Stefano Margaritora, Alfredo Cesario, Rolando M. D’Angelillo, Gina Gualano, Sara Ramella, Domenico Galetta, and Numa Cellini
	JCO Feb 1 2002: 804–810. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Bax Expression Decreases Significantly From Primary Tumor to Metastasis in Colorectal Cancer
	Agneta Jansson and Xiao-Feng Sun
	JCO Feb 1 2002: 811–816. [Abstract] [Full Text] [PDF]
	Acute Side Effects and Complications After Short-Term Preoperative Radiotherapy Combined With Total Mesorectal Excision in Primary Rectal Cancer: Report of a Multicenter Randomized Trial
	C. A.M. Marijnen, E. Kapiteijn, C. J.H. van de Velde, H. Martijn, W. H. Steup, T. Wiggers, E. Klein Kranenbarg, and J. W.H. Leer
	JCO Feb 1 2002: 817–825. [Abstract] [Full Text] [PDF]

Epidemiology
	Up-to-Date Long-Term Survival Curves of Patients With Cancer by Period Analysis
	Hermann Brenner and Timo Hakulinen
	JCO Feb 1 2002: 826–832. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Association of Preoperative Plasma Levels of Insulin-Like Growth Factor I and Insulin-Like Growth Factor Binding Proteins-2 and -3 With Prostate Cancer Invasion, Progression, and Metastasis
	Shahrokh F. Shariat, Dolores J. Lamb, Michael W. Kattan, Cuong Nguyen, JaHong Kim, Josie Beck, Thomas M. Wheeler, and Kevin M. Slawin
	JCO Feb 1 2002: 833–841. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Role of Radiotherapy in the Treatment of Supratentorial Primitive Neuroectodermal Tumors in Childhood: Results of the Prospective German Brain Tumor Trials HIT 88/89 and 91
	Beate Timmermann, Rolf-Dieter Kortmann, Joachim Kühl, Christoph Meisner, Karin Dieckmann, Torsten Pietsch, and Michael Bamberg
	JCO Feb 1 2002: 842–849. [Abstract] [Full Text] [PDF]

Tumor Biology
	Prospective Evaluation of the Peptide-Bound Collagen Type I Cross-Links N-Telopeptide and C-Telopeptide in Predicting Bone Metastases Status
	Luis Costa, Laurence M. Demers, A. Gouveia-Oliveira, J. Schaller, Eduardo B. Costa, Miguel C. de Moura, and Allan Lipton
	JCO Feb 1 2002: 850–856. [Abstract] [Full Text] [PDF]

Central Nervous System
	Induction Chemotherapy Followed by Low-Dose Involved-Field Radiotherapy for Intracranial Germ Cell Tumors
	Hidefumi Aoyama, Hiroki Shirato, Jun Ikeda, Kenji Fujieda, Kazuo Miyasaka, and Yutaka Sawamura
	JCO Feb 1 2002: 857–865. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Challenges in Oncology: Case 1. Oncology Emergencies: A Myeloma Patient with Stridor

W. Y. Au, C. G.C . Ooi, K. H. Li, T. W. Shek, and R. Liang

JCO Feb 1 2002: 866–867. [Full Text] [PDF]

Challenges in Oncology: Case 2. Radiation Recall Associated With Docetaxel

Muffaddal Morkas, Donald Fleming, and Michael Hahl

JCO Feb 1 2002: 867–869. [Full Text] [PDF]

Challenges in Oncology: Case 3. Depigmentation in a Chronic Myeloid Leukemia Patient Treated With STI-571

Pia Raanani, John M. Goldman, and Isaac Ben-Bassat

JCO Feb 1 2002: 869–870. [Full Text] [PDF]

Challenges in Oncology: Case 4. Response of Metastatic Gastrointestinal Stromal Tumor Including CNS Involvement to Imatinib Mesylate (STI-571)

B. Jay Brooks, J. Cary Bani, Christopher D.M. Fletcher, and George D. Demetri

JCO Feb 1 2002: 870–872. [Full Text] [PDF]

ART OF ONCOLOGY

Why Me?

David P. Steensma

JCO Feb 1 2002: 873–875. [Full Text] [PDF]

SPECIAL DEPARTMENTS

CORRESPONDENCE

Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy

Aman U. Buzdar, H. Mouridsen, and H. A. Chaudri-Ross

JCO Feb 1 2002: 876–878. [Full Text] [PDF]

Clinical Evaluation of Once-Weekly and Three-Times-Weekly Dosings of Epoetin Alfa in Chemotherapy Patients: Problems of Study Design and Interpretation

Tuan V. Nguyen and Giang N. Trinh

JCO Feb 1 2002: 878–879. [Full Text] [PDF]

Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer

Richard R. Love, Aron Goldhirsch, John H. Glick, Richard D. Gelber, Alan S. Coates, and Hans-Jörg Senn

JCO Feb 1 2002: 879–880. [Full Text] [PDF]

Role of Symptom Control and Palliative Care Abstract Presentations

Jamie H. Von Roenn, David Scheinberg, Patrick J. Loehrer, Sr, Catherine Sweeney, Leaha Beattie-Palmer, J. Lynn Palmer, and Eduardo Bruera

JCO Feb 1 2002: 880–882. [Full Text] [PDF]

Regression of Mucosa-Associated Lymphoid Tissue Lymphoma of the Bladder After Antibiotic Therapy

D. Oscier, J. Bramble, E. Hodges, and D. Wright

JCO Feb 1 2002: 882. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.